Clinical Trial

miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups. Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-11-29; most recent amendment 2026-03-16.
Trial Details
NCT Number NCT05632055
Lead Sponsor Chiang Mai University
Conditions Gestational Diabetes
Enrollment 160 participants
Start Date 2000-08-26
Primary Completion 2022-11-21 (estimated)
Study Completion 2026-03-17 (estimated)
Updated on ClinicalTrials.gov 2026-03-18